Our findings emphasize that inhibition of IMPDH could repress the proliferation, migration and invasion capabilities of HNSCC cells by decreasing GTP production, expanding the scope of IMPDH1 inhibitors in anti-tumor therapy. The gene discussed is IMPDH1; the disease is head and neck squamous cell carcinoma.